Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart

Circulation Research

Volumn 86, Issue 1, 2000, Pages 43-50

  Eckhart, Andrea D ^a   Duncan, Sandra J ^a   Penn, Raymond B ^b   Benovic, Jeffrey L ^b   Lefkowitz, Robert J ^a   Koch, Walter J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adrenergic receptors, 1; Desensitization; Myocardial biology; Myocardial hypertrophy; Protein coupled receptor kinase

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ATRIAL NATRIURETIC FACTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; ENZYME SPECIFICITY; GENE OVEREXPRESSION; HEART; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0033982570     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.1.43     Document Type: Article

References (37)

1. 1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. J Biol Chem. 1996;271: 5839-5843.
2. 1-adrenergic receptor mRNA species in rat heart. J Cardiovasc Pharmacol. 1998;32:117-122.
3. Exton JH. Role of G proteins in activation of phosphoinositide phospholipase C. Adv Second Messenger Phosphoprotein Res. 1993;28:65-72.
4. Puceat M, Hilal-Dandan R, Strulovici B, Brunton LL, Brown JH. Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes. J Biol Chem. 1994;269:16938-16944.
5. Akhter SA, Luttrell LM, Rockman HA, Lefkowitz RJ, Koch WJ. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 1998;280:574-577.
6. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 1991;5:3037-3046.
7. Simpson PC. Transcription of early development isogenes in cardiac myocyte hypertrophy. J Mol Cell Cardiol. 1983;72:732-738.
8. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA. 1994;91:10109-10113.
9. Lefkowitz RJ. G protein-coupled receptors, III: new roles for receptor kinases and β-arrestins in receptor signaling and desensitization. J Biol Chem. 1998; 273:18677-18680.
10. Inglese J, Freedman NJ, Koch WJ, Lefkowitz RJ. Structure and mechanisms of the G protein-coupled receptor kinase. J Biol Chem. 1993;268: 23735-23738.
11. Freedman NJ, Liggett SB, Drachman DE, Pei G, Caron MG, Lefkowitz RJ. Phosphorylation and desensitization of the human β1-adrenergic receptor involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase. J Biol Chem. 1995;270:17953-17961.
12. 1B-adrenergic receptor. J Biol Chem. 1996;271:5049-5058.
13. Oppermann M, Freedman NJ, Alexander RW, Lefkowitz RJ. Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C. J Biol Chem. 1996;271:13266-13272.
14. Freedman NJ, Ament AS, Oppermann M, Stoffel RH, Exum ST, Lefkowitz RJ. Phosphorylation and desensitization of human endothelin A and B receptors: evidence for G protein-coupled receptor kinase specificity. J Biol Chem. 1997;272:17734-17743.
15. 1 adenosine receptor-mediated responses. Mol Pharmacol. 1999;56:316-324.
16. Koch WJ, Rockman HA, Samama P, Hamilton R, Bond RA, Milano CA, Lefkowitz RJ. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science. 1995;268:1350-1353.
17. Rockman HA, Choi D-J, Rahman NU, Akhter SA, Lefkowitz RJ, Koch WJ. Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. Proc Natl Acad Sci USA. 1996;93:9954-9959.
18. Iaccarino G, Rockman HA, Shotwell KF, Tomhave ED, Koch WJ. Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. Am J Physiol. 1998;275:H1298-H1306.
19. Koch WJ, Milano CA, Lefkowitz RJ. Transgenic manipulation of myocardial G protein-coupled receptors and receptor kinases. Circ Res. 1996;78: 511-516.
20. 1-adrenergic receptor-mediated regulation of β-adrenergic signaling. J Biol Chem. 1997;272:21253-21259.
21. 1-adrenergic stimulation. Hypertension. 1999;33:396-401.
22. Choi DJ, Koch WJ, Hunter JJ, Rockman HA. Mechanism of β-adrenergic receptor desensitization in cardiac hypertrophy is increased β-adrenergic receptor kinase. J Biol Chem. 1997;272:17223-17229.
23. Thorbum J, Frost JA, Thorburn A. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J Cell Biol. 1994;126:1565-1572.
24. Bogoyevitch MA, Andersson MB, Gillespie-Brown J, Clerk A, Glennon PE, Fuller SJ, Sugden PH. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J. 1996;314: 115-121.
25. Glennon PE, Kaddoura S, Sale EM, Sale GJ, Fuller SJ, Sugden PH. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res. 1996;78:954-961.
26. Ishii K, Chen J, Ishii M, Koch WJ, Freedman NJ, Lefkowitz RJ, Coughlin SR. Inhibition of thrombin receptor signaling by a G-protein coupled receptor kinase: functional specificity among G-protein coupled receptor kinases. J Biol Chem. 1994;269:1125-1130.
27. Pitcher JA, Inglese J, Higgins JB, Arriza JL, Casey PJ, Kim C, Benovic JL, Kwatra MM, Caron MG, Lefkowitz RJ. Role of βγ subunits of G proteins in targeting the β-adrenergic receptor kinase to membrane-bound receptors. Science. 1992;257:1264-1267.
28. Koch WJ, Inglese J, Stone WC, Lefkowitz RJ. The binding site for the βγ subunits of heterotrimeric G proteins on the β-adrenergic receptor kinase. J Biol Chem. 1993;268:8256-8260.
29. Chuang TT, Pompili E, Paolucci L, Sallese M, DeGioia L, Salmona M, DeBlasi A. Identification of a short sequence highly divergent between β-adrenergic receptor kinases 1 and 2 that determines the affinity of binding to βγ subunits of heterotrimeric guanine-nucleotide-binding regulatory proteins. Eur J Biochem. 1997;245:533-540.
30. Touhara K, Koch WJ, Hawes BE, Lefkowitz RJ. Mutational analysis of the plekstrin homology domain of the β-adrenergic receptor kinase: differential effects on Gβγ and phosphatidylinositol 4,5-bisphosphate binding. J Biol Chem. 1995;270:17000-17005.
31. Daaka Y, Pitcher JA, Richardson M, Stoffel RH, Robishaw JD, Lefkowitz RJ. Receptor and Gβγ isoform-specific interactions with G protein-coupled receptor kinases. Proc Natl Acad Sci U S A. 1997;94:2180-2185.
32. Calderone A, Thaik CM, Takahashin N, Chang DDLF, Colucci WS. Nitric oxide, atrial natriuretic peptide and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest. 1998;101:812-818.
33. Cao L, Gardner DG. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension. 1995;25:227-234.
34. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990;86:1690-1697.
35. Silberbach M, Gorenc T, Hershberger RE, Stork PJ, Steyger PS, Roberts CT Jr. Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J Biol Chem. 1999;274:24858-24864.
36. Lohse MJ, Engelhardt S, Danner S, Bohm M. Mechanisms of β-adrenergic receptor desensitization: from molecular biology to heart failure. Basic Res Cardiol. 1996;91:29-34.
37. 1-adrenergic activity in cardiomyopathic Syrian hamster. Am J Physiol. 1991;260:H80-H88.